François-Michel Boisvert initially received a BSc in Biochemistry in 1998 at the Université de Montréal. He then pursued a research career with a MSc in Biochemistry and Molecular Biology in 2000 at the University of Calgary under the supervision of Professor David P. Bazett-Jones and a PhD in Experimental Medicine in 2005 at McGill University with Professor Stéphane Richard. He conducted postdoctoral training with Professor Angus Lamond at the University of Dundee and is a professor in the Immunology and Cell Biology department at the Université de Sherbrooke since 2011. His current interests is studying the molecular mechanisms that control the cellular response to DNA damaging agents used to treat colorectal cancer using a combination of cell biology combined with mass spectrometry based quantitative proteomic approaches. He is the director of the Cancer Research Institute of the Université de Sherbrooke, and also the scientific director of the Proteomics Facility at the Université de Sherbrooke.